Mirae Asset Global Investments’s Xenon Pharmaceuticals XENE Stock Holding History

Mirae Asset Global Investments’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	4,323 -16	-0.4%	-$888	﹤0.01%	1078
2026 Q1	$252K	Buy	4,339 +584	+16%	+$26.9K	﹤0.01%	1043
2025 Q4	$168K	Buy	3,755 +774	+26%	+$32.5K	﹤0.01%	1170
2025 Q3	$120K	Buy	2,981 +17	+0.6%	+$599	﹤0.01%	1182
2025 Q2	$92.8K	Buy	2,964 +403	+16%	+$13.1K	﹤0.01%	1150
2025 Q1	$87.7K	Buy	2,561 +20	+0.8%	+$759	﹤0.01%	1140
2024 Q4	$98.7K	Sell	2,541 -199	-7%	-$8.23K	﹤0.01%	1149
2024 Q3	$106K	Buy	2,740 +487	+22%	+$19.6K	﹤0.01%	1176
2024 Q2	$84.3K	Buy	+2,253	New	+$90.1K	﹤0.01%	1163

Other funds holding XENE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Mirae Asset Global Investments's XENE Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Xenon Pharmaceuticals (XENE) stake by 0.37% in Q2 2026, selling an estimated $888 and leaving 4,323 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

Mirae Asset Global Investments first reported a position in XENE in Q2 2024 and has held it in 9 quarters since. 99 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Mirae Asset Global Investments held 4,323 shares of Xenon Pharmaceuticals worth $261K as of Q2 2026.
Mirae Asset Global Investments sold 16 Xenon Pharmaceuticals shares in Q2 2026, an estimated $888.
Xenon Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1078 holding.
Mirae Asset Global Investments first reported a position in Xenon Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
99 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.